The Neuro’s drug discovery initiative supports research by developing assays shared with the scientific community
In the past 40 years, the model of drug discovery used by the pharmaceutical industry, while proving successful for some applications, has produced very little for neurodegenerative diseases.
“We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”“Take Parkinson’s disease, for instance: there have been zero new disease modifying medications developed in the last 40 years, despite hundreds of millions of dollars being invested in research,” says Dr. Edward Fon, whose lab focuses on molecular and cellular research into Parkinson’s disease. “We have to ask if there is a better way to find therapies that will modify the course of diseases, slowing or stopping them from progressing. While Open Science is not going to solve every problem, it will be a big part of the solution.”
The Neuro’s drug discovery initiative aims to support research by developing assays that investigate different aspects of target cells and sharing these assays with colleagues around the world. The main vehicle for sharing assays is The Neuro’s Induced Pluripotent Stem Cell (iPSC) platform, developed recently with seed money generously donated by Sebastian van Berkom and Ghislaine Saucier.
“We can provide industry-standard assays researchers can use to test compounds,” says Thomas Durcan, another Parkinson’s researcher who manages the iPSC platform. “In collaboration with researchers at Université Laval, we reprogram blood cells from patients with neurological diseases into stem cells, and then transform the stem cells into the type of neural cells most impacted in neuropathology.”
This gives researchers the ability to compare normal and diseased states of the cells within one patient, which has long been possible for some diseases but is a novel advance for neurological research. The Centre for Drug Research and Development, a Canadian nonprofit organization that aims to speed the translation of discoveries into therapies, and the international Structural Genomics Consortium have both formed partnerships with the Tanenbaum Open Science Institute to use the iPSC platform.
“If we can identify potential compounds for targeting diseases such as Parkinson’s and share them so they can be screened and tested throughout the scientific community, we can accelerate the rate of discovery,” says Dr. Fon. “Other researchers can benefit from the resources we develop, and the chances of 100 laboratories finding something useful is much greater than that of one lab working alone. If we can come up with something leading to treatment for Parkinson’s disease, that would be an incredible payback.”
Learn more: Accelerating drug discovery with Open Science
The Latest on: Open Science
[google_news title=”” keyword=”Open Science” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Open Science
- Open Science and Agroecology: A Conversation with Miguel Ángel Núñezon April 26, 2024 at 9:00 am
An independent researcher argues that Venezuela is undergoing an agroecological transition and explains its importance.
- Vast DNA tree of life for plants revealed by global science team using 1.8 billion letters of genetic codeon April 24, 2024 at 8:00 am
A new paper published today (April 24) in the journal Nature by an international team of 279 scientists led by the Royal Botanic Gardens, Kew presents the most up-to-date understanding of the ...
- Empowering Global Climate Efforts: NASA’s Integration of AI and Open Scienceon April 20, 2024 at 6:12 am
To construct an expansive foundation model, we acknowledged the necessity for collaboration beyond a singular entity,” Maskey stated. “Our endeavors surrounding foundation models have been accessible ...
- AI for Earth: How NASA's artificial intelligence and open science efforts combat climate changeon April 19, 2024 at 10:33 am
As extreme weather events increase around the world due to climate change, the need for further research into our warming planet has increased as well. For NASA, climate research involves not only ...
- The power of open science: Frontiers’ collaborative approach to addressing climate changeon April 17, 2024 at 5:00 pm
The COVID-19 pandemic demonstrated the power of open science to solve a global issue. In the US, the White House, along with a coalition of research organizations, launched the COVID-19 Open ...
- Open principles reaffirm Digital Science’s commitment to open researchon April 16, 2024 at 12:05 pm
Digital Science has today launched its Open Principles, a new initiative that commits its research information solutions to open science now and into the future. The Principles are the first step ...
- Open Scienceon April 4, 2024 at 6:41 am
The University of Münster is committed to the principles of open science. Research transparency and reliability are essential criteria for good scientific practice and a basic prerequisite for the ...
- About ESA Open Scienceon May 9, 2023 at 8:10 am
Open science is the idea that the products and the process of science should be freely accessible (i.e. open) to everyone. This includes things like open educational materials, open access ...
- Starting to practice Open Scienceon May 9, 2023 at 8:10 am
Open access (free access without request) publications are an easy way to start practicing open science. There are two type of open access, green and gold. Both are open, and both work to give folks ...
- Open Scienceon December 5, 2022 at 5:33 am
Reference it! Need help finding information on a specific topic? Contact the Science and Engineering team by emailing [email protected]. In this guide, we are gathering links to Open Science ...
via Bing News